The contribution
What this work established
Franz and colleagues showed in laboratory Candida cultures that exposure to fluconazole changes the organism’s sensitivity to copper availability. Their chemical analyses distinguished this biological interaction from simply forming a copper–drug complex. The result links an established antifungal drug’s effects to the metal conditions surrounding the treated cells.
Why this matters to microbial metallomics
This points to a concrete opportunity for metallomics in medicine: the chemical environment can influence how a drug performs. Franz’s work gives researchers a way to examine metal–drug interactions mechanistically, including location and speciation, before assuming that adding a metal or a chelator will improve treatment.
The next scientific question
The next translational question is whether these interactions persist in infected tissues with acceptable host safety and demonstrable clinical benefit; laboratory growth effects alone cannot establish that.
Research background
Investigates how biological systems manage the coordination chemistry of essential but potentially toxic metals, especially copper and iron. Her laboratory develops chemical tools to change metal location, speciation and reactivity, including approaches relevant to microbial pathogens.
The contribution is grounded in the linked sources. Its significance and future directions are this guide’s editorial synthesis. Inclusion does not imply endorsement of this website.